The complexity and heterogeneity of protein therapeutics present significant challenges in biologics discovery, as ...

REDWOOD CITY, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--InterVenn Biosciences today announced that it has made its proprietary mass spectrometry analysis software available for public use. Powered ...

Imagine if diagnosis and treatment for devastating conditions such as Alzheimer’s disease could be developed quickly by extensive profiling of protein signatures in human tissues. This vision may not ...

Swiss-based Roche announced this month that it has received U.S. regulatory clearance for a less-complex vitamin D test in the United States, which the company said opens the door to more efficient ...

After decades of nonstarters, blood tests for Alzheimer’s disease are finally here, enabling researchers to predict who may have amyloid plaques in their brain. Among the candidate tests jostling for ...

BUFFALO, N.Y. ­— Imagine if diagnosis and treatment for devastating conditions such as Alzheimer’s disease could be developed quickly by extensive profiling of protein signatures in human tissues.